The Patent Finder

Terms ending in 2035

Pfizer Inc.

Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,492,559Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,105,431Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,918,708Streptococcus Pneumoniae Capsular Polysaccharides and Conjugates Thereof
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 11,090,375Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 11,160,855Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 11,426,456Streptococcus Pneumoniae Capsular Polysaccharides and Conjugates Thereof
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,616,744Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
In force
 · Low confidence
Pfizer Inc.In forceLow confidence
US 10,086,085Bifunctional Cytotoxic Agents
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,391,182Bifunctional Cytotoxic Agents
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 10,570,202Combination of a PD-1 Antagonist and a Vegfr Inhibitor for Treating Cancer
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
74 more term ends in 2035 · Pro
10 of 84 patents shown. Soonest term end first, then patent number.
Pro members see all 84.
Upgrade to Pro
73 of these are in force and held by Pfizer Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited